These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22216257)

  • 21. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis.
    Zhang Y; Ogbu D; Garrett S; Xia Y; Sun J
    Gut Microbes; 2021; 13(1):1996848. PubMed ID: 34812107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
    Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
    Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice.
    Kaneb HM; Sharp PS; Rahmani-Kondori N; Wells DJ
    PLoS One; 2011; 6(9):e24189. PubMed ID: 21909419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intact single muscle fibres from SOD1
    Cheng AJ; Allodi I; Chaillou T; Schlittler M; Ivarsson N; Lanner JT; Thams S; Hedlund E; Andersson DC
    J Physiol; 2019 Jun; 597(12):3133-3146. PubMed ID: 31074054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1
    Hazell G; McCallion E; Ahlskog N; Sutton ER; Okoh M; Shaqoura EIH; Hoolachan JM; Scaife T; Iqbal S; Bhomra A; Kordala AJ; Scamps F; Raoul C; Wood MJA; Bowerman M
    Skelet Muscle; 2024 Oct; 14(1):23. PubMed ID: 39396990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
    J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model.
    Li W; Fotinos A; Wu Q; Chen Y; Zhu Y; Baranov S; Tu Y; Zhou EW; Sinha B; Kristal BS; Wang X
    Neurobiol Dis; 2015 Aug; 80():93-103. PubMed ID: 25986728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological inhibition of complement C5a-C5a
    Lee JD; Kumar V; Fung JN; Ruitenberg MJ; Noakes PG; Woodruff TM
    Br J Pharmacol; 2017 Apr; 174(8):689-699. PubMed ID: 28128456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.
    Patel BP; Safdar A; Raha S; Tarnopolsky MA; Hamadeh MJ
    PLoS One; 2010 Feb; 5(2):e9386. PubMed ID: 20195368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis.
    Zhang X; Chen S; Song L; Tang Y; Shen Y; Jia L; Le W
    Autophagy; 2014 Apr; 10(4):588-602. PubMed ID: 24441414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen receptor antagonism accelerates disease onset in the SOD1
    McLeod VM; Lau CL; Chiam MDF; Rupasinghe TW; Roessner U; Djouma E; Boon WC; Turner BJ
    Br J Pharmacol; 2019 Jul; 176(13):2111-2130. PubMed ID: 30849180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice.
    Chen HH; Yeo HT; Huang YH; Tsai LK; Lai HJ; Tsao YP; Chen SL
    Skelet Muscle; 2024 Jul; 14(1):17. PubMed ID: 39044305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.
    Liu KX; Edwards B; Lee S; Finelli MJ; Davies B; Davies KE; Oliver PL
    Brain; 2015 May; 138(Pt 5):1167-81. PubMed ID: 25753484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.